Improving a better class of cancer drugs
Friday, September 11, 2015 - 13:30
in Health & Medicine
A class of therapeutic drugs known as protein kinase inhibitors has become a powerful weapon in the fight against various life-threatening diseases. One problem with these drugs, however, is that they often inhibit many different targets, which can lead to side effects and complications in therapeutic use. A recent study has identified a new technique for improving the selectivity of these drugs and possibly decreasing unwanted side effects in the future.